<DOC>
	<DOCNO>NCT00409019</DOCNO>
	<brief_summary>The purpose study find take combination telbivudine adefovir tenofovir telbivudine lower amount Hepatitis B virus patient take adefovir alone least 5 month less optimal response . The safety take telbivudine adefovir together tenofovir telbivudine together also study .</brief_summary>
	<brief_title>Trial Telbivudine Combination Therapy v . Continued Adefovir Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Telbivudine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Documented compensate chronic hepatitis B define clinical history compatible chronic hepatitis B Patient currently receive Hepsera ( adefovir dipivoxil ) receive treatment continuously minimum 5 month prior screen . Other inclusion criterion may apply . Patient pregnant breastfeeding Patient coinfected hepatitis C , hepatitis D HIV Patient previously receive nucleoside ( tide ) therapy adefovir Patient previously receive interferonbased treatment investigational agent hepatitis B precede 12 month Other exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>